Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy

Xiaohua Wang1, Yang Zhou, Ruoyun Tan

  • 1Center of Kidney Disease, 2nd Affiliated Hospital, Nanjing Medical Univ., 262 Zhongshan East Rd., Nanjing 210003, Jiangsu Province, China.

Insights

Matrix metalloproteinase-9 (MMP-9) deficiency protects against kidney fibrosis by preventing tubular basement membrane damage and epithelial-to-myofibroblast transition. This highlights MMP-9

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • The role of matrix metalloproteinase-9 (MMP-9) in renal interstitial fibrosis is not well understood.
  • Renal interstitial fibrosis is a common pathway for progressive kidney diseases.
  • Obstructive nephropathy is a model for studying kidney fibrosis.

Purpose of the Study:

  • To investigate the role of MMP-9 in the pathogenesis of renal interstitial fibrosis.
  • To determine if MMP-9 contributes to kidney injury and fibrosis in obstructive nephropathy.

Main Methods:

  • Utilized a mouse model of obstructive nephropathy.
  • Compared wild-type mice with mice lacking MMP-9 (MMP-9 knockout).
  • Assessed kidney injury, tubular basement membrane (TBM) integrity, fibronectin expression, collagen deposition, and epithelial-to-myofibroblast transition (EMT).

Main Results:

  • Mice lacking MMP-9 showed attenuated renal interstitial fibrotic lesions and morphological injury.
  • MMP-9 deficiency reduced TBM disruption, fibronectin expression, and collagen deposition in obstructed kidneys.
  • MMP-9 deficiency blocked tubular EMT but did not affect TGF-β1 axis induction; in vitro studies showed MMP-9-digested TBM promotes EMT.

Conclusions:

  • Matrix metalloproteinase-9 plays a detrimental role in renal interstitial fibrogenesis.
  • MMP-9 contributes to fibrosis by causing TBM destruction, which promotes EMT.
  • Ablation of MMP-9 offers a protective effect against kidney fibrosis in obstructive nephropathy.

Related Concept Videos